Clinical Trial Update: Effects of Topical Diclofenac on Tumor Metabolism [Phase 4]

View source ↗

Summary

This document notes the completion of a Phase 4 clinical trial evaluating the effects of topical diclofenac on tumor metabolism in actinic keratoses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratoses

Drugs mentioned

• Diclofenac topical (diclofenac)

Snippet

Sponsor: University Hospital Regensburg | Conditions: Actinic Keratoses | Phase 4 | Status: COMPLETED